Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer

December 06, 2023 00:21:52
Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer
COR2ED - Oncology Medical Conversation
Thyroid cancer: Optimising VEGFR-TKIs (MKIs) in differentiated thyroid cancer

Dec 06 2023 | 00:21:52

/

Show Notes

Dr. Jaume Capdevila, a Medical Oncologist at Vall d’Hebron University Hospital in Barcelona, Spain, and Dr. Rachel van Leeuwaarde, an Endocrinologist from the University Medical Center of Utrecht in The Netherlands discuss the use of multi-kinase inhibitors (MKIs), in particular VEGFR-TKIs in patients with radioactive iodine refractory differentiated thyroid cancer (DTC).

In this podcast, the two experts discuss key trials (SELECT, DECISION and COSMIC-311) and efficacy parameters of the current VEGFR-TKIs (lenvatinib, sorafenib and cabozantinib), how to manage toxicity whilst trying to optimise treatment outcomes and preserving always patients’ quality of life. They also discuss treatment strategies, when to start systemic treatment, which drug should be used first and how to sequence therapies. To close the podcast they take a look at ongoing clinical trials with other treatments in development for DTC.

Other Episodes

Episode

December 06, 2023 00:24:10
Episode Cover

Lower GI cancer: Highlights from ASCO GI 2023 - Part 2

This episode, covers the highlights on colorectal cancer from ASCO GI 2023.  Prof. Andrea Sartore-Bianchi (Niguada Cancer Center, Milan, Italy) and Prof. Shubham Pant...

Listen

Episode

December 06, 2023 00:19:43
Episode Cover

Prostate cancer: PARP inhibitors. Part 2 - Combination therapy; US and EU perspectives

Dr Neal Shore, Uro-Oncologist and Chief Medical Officer for Genesis Care and Urology and Surgical Oncology in the United States and Dr Elena Castro,...

Listen

Episode

December 06, 2023 00:16:16
Episode Cover

Gastric and GEJ cancers: Clinical case discussions. Part 2 - metastatic disease

This podcast series consists of two episodes where expert oncologists Dr Sam Klempner (Massachusetts General Hospital, USA) and Dr Lizzy Smyth (Oxford University Hospitals...

Listen